Contemporary management of hepatoblastoma
Authors:
- 1 April 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 24 (2) , 113-117
Abstract
Purpose of review: Hepatoblastoma is the most common primary pediatric liver malignancy. The goal of treatment in hepatoblastoma is complete surgical resection. Recently published multinational collaborative studies are better defining risk factors for disease recurrence and guide optimal treatment strategy. Recent findings: Successful margin-negative resection of hepatoblastoma is dependent on the location and extent of disease as defined by the PRETEXT classification. Liver transplantation is an appropriate treatment modality when complete oncological resection requires total hepatectomy. In general, advanced PRETEXT class as well as histologic features, age at presentation, tumoral production of α-feto protein and the presence of metastatic disease adversely affect outcome. Hepatoblastoma is chemosensitive and significant downstaging can occur with the use of neoadjuvant chemotherapy allowing for less extensive hepatectomy. In addition, patients at moderate-to-high risk of postresection recurrence should receive neoadjuvant chemotherapy. Cisplatin-based chemotherapy can allow for resection of transplantation of patients with metastatic disease when complete metasatectomy can be achieved albeit with inferior results. Summary: Treatment of hepatoblastoma with surgical resection or liver transplantation is associated with excellent long-term results in the setting of modern chemotherapy.Keywords
This publication has 26 references indexed in Scilit:
- Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screeningPediatric Blood & Cancer, 2018
- Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children’s Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children’s Oncology GroupJournal of Clinical Oncology, 2017
- HepatoblastomaSeminars in Diagnostic Pathology, 2017
- Cancer Risk in Beckwith-Wiedemann Syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening ProtocolThe Journal of Pediatrics, 2016
- Hepatoblastoma Associated with Trisomy 18Journal of Pediatric Genetics, 2015
- Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposiumLaboratory Investigation, 2014
- Hepatoblastoma state of the artCurrent Opinion in Pediatrics, 2014
- Hepatoblastoma state of the artCurrent Opinion in Pediatrics, 2014
- Relapses in hepatoblastoma patients: Clinical characteristics and outcome – Experience of the International Childhood Liver Tumour Strategy Group (SIOPEL)European Journal of Cancer, 2013
- Hepatoblastoma in children of extremely low birth weight: A report from a single perinatal centerJournal of Pediatric Surgery, 2003